Morepen Laboratories Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

102.23

95.56

89.96

89.96

89.96

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

677.89

502.61

311.26

217.29

187.50

Loan funds

Secured loans

25.16

18.57

59.90

12.28

10.78

Unsecured loans

-

-

-

-

-

Total

805.28

616.74

461.13

319.53

288.24

Uses of funds

Fixed assets

Gross block

496.81

470.18

512.78

628.45

768.84

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

325.99

314.07

368.75

493.61

616.25

Net block

170.82

156.11

144.02

134.84

152.59

Capital work-in-progress

17.01

14.15

1.96

-

-

Investments

117.84

117.79

118.78

118.78

117.72

Net current assets

Current assets, loans & advances

799.86

745.21

582.74

408.37

349.08

Less : current liabilities & provisions

300.26

416.53

386.37

342.45

331.15

Total net current assets

499.60

328.69

196.37

65.91

17.93

Miscellaneous expenses not written

-

-

-

-

-

Total

805.28

616.74

461.13

319.53

288.24

Notes:

Book value of unquoted investments

117.84

117.79

117.69

117.69

117.69

Market value of quoted investments

-

-

1.31

0.75

0.02

Contingent liabilities

11.84

18.98

3.36

1.27

11.52

Number of equity sharesoutstanding (Lacs)

5111.69

4778.26

4498.26

4498.26

4498.26